Explore breakthrough studies, computational design techniques, and therapeutic applications in protein science
Exploring CD19-TRAIL fusion protein, a targeted immunotherapy for B-cell precursor acute lymphoblastic leukemia (BCP-ALL) with promising preclinical results.